NCT01794169View on ClinicalTrials.gov

Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

PHASE2TerminatedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

March 31, 2018

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

Azacitidine

DRUG

DA

Trial Locations (1)

17176

Karolinska University Hospital, Solna, Stockholm

Sponsors

Collaborators (1)

Celgene Corporation

All Listed Sponsors

collaborator

Celgene Corporation

INDUSTRY

lead

Karolinska University Hospital

OTHER